Demonstration of CWA-Reactive, Non-Irritating rTSPFormulations (MEC Proposal No.808DB2054)

Mainstream has demonstrated the effectiveness of a new family of metal alloy powders (patent-pending) in immobilizing chemicals such as halocarbons, alkenes, and H and G CWA simulants. These materials must now be feasibility tested in complete product formulations. There is also the potential for unexpected synergisms of these compounds with the other skin cream ingredients. A considerable amount of money and time has already been spent analyzing intricate details of surface chemistry and reaction mechanisms for several proposed rTSP's, and yet there is still a demand for effective rTSP's as per this repested SBIR solicitation topic. This may not be a coincidence. Our Tibbetts award-winning and commercial-minded approach is to efficiently use the SBIR funding to determine concept feasibility by product demonstration. The university or part of a Phase II can delve into the chemistry details after the feasibility of the complete rTSP product is proven successful. This Phase I will evaluate several reactive materials formulated into barrier cream formulations (e.g., perfluorinated polyether oil and PTFE thickeners) for reactivity and barrier capability toward several simulants, ingredient synergisms, potential skin irritation, cost, and approximate stoichiometry of products. Protective skin creams for personnel routinely exposed to toxic materials (e.g., toxic chemicals, nerve agents, plant related toxins such as poison ivy, pesticides, and herbicides) would benefit both commercial and military users. Examples are chemical warfare environments, police riot control, pesticide workers, and protection from poisonous plants and animals.